Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Disease and meta-analysis and APOC3[original query] |
|---|
Newly identified loci that influence lipid concentrations and risk of coronary artery disease.
Nature genetics 2008 Feb 40 (2): 161-9. Willer Cristen J, Sanna Serena, Jackson Anne U, Scuteri Angelo, Bonnycastle Lori L, Clarke Robert, Heath Simon C, Timpson Nicholas J, Najjar Samer S, Stringham Heather M, Strait James, Duren William L, Maschio Andrea, Busonero Fabio, Mulas Antonella, Albai Giuseppe, Swift Amy J, Morken Mario A, Narisu Narisu, Bennett Derrick, Parish Sarah, Shen Haiqing, Galan Pilar, Meneton Pierre, Hercberg Serge, Zelenika Diana, Chen Wei-Min, Li Yun, Scott Laura J, Scheet Paul A, Sundvall Jouko, Watanabe Richard M, Nagaraja Ramaiah, Ebrahim Shah, Lawlor Debbie A, Ben-Shlomo Yoav, Davey-Smith George, Shuldiner Alan R, Collins Rory, Bergman Richard N, Uda Manuela, Tuomilehto Jaakko, Cao Antonio, Collins Francis S, Lakatta Edward, Lathrop G Mark, Boehnke Michael, Schlessinger David, Mohlke Karen L, Abecasis Gonçalo |
| Apolipoprotein c3 gene polymorphisms are not a risk factor for developing non-alcoholic Fatty liver disease: a meta-analysis. Hepatitis monthly 2014 Oct 14 (10): e23100. Zhang Haiying, Chen Lizhen, Xin Yongning, Lou Yuangui, Liu Yang, Xuan Shiyi |
| Association between apolipoprotein C3 Sst I, T-455C, C-482T and C1100T polymorphisms and risk of coronary heart disease. BMJ open 2014 4 (1): e004156. Lin Bin, Huang Yiwei, Zhang Mingying, Wang Jun, Wu Yih |
| Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study. Lipids in health and disease 2015 14 (1): 113. Yang Guang, Lei Ming-Ming, Yu Chun-Lei, Liu Xiao-Xiao, An Zhe, Song Chun- |
| Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study. Atherosclerosis 2015 Aug 241 (2): 641-8. Pokharel Yashashwi, Sun Wensheng, Polfus Linda M, Folsom Aaron R, Heiss Gerardo, Sharrett A Richey, Boerwinkle Eric, Ballantyne Christie M, Hoogeveen Ron |
| Apolipoprotein C3 gene variants and the risk of coronary heart disease: A meta-analysis. Meta gene 2016 Sep 9 104-9. Li Yan, Li Chao, Gao J |
| Association between Apolipoprotein C-III Gene Polymorphisms and Coronary Heart Disease: A Meta-analysis. Aging and disease 2016 Jan 7 (1): 36-44. Zhang Jing-Zhan, Xie Xiang, Ma Yi-Tong, Zheng Ying-Ying, Yang Yi-Ning, Li Xiao-Mei, Fu Zhen-Yan, Dai Chuan-Fang, Zhang Ming-Ming, Yin Guo-Ting, Liu Fen, Chen Bang-Dang, Gai Min-T |
| APOA5 -1131T>C and APOC3 -455T>C polymorphisms are associated with an increased risk of coronary heart disease. Genetics and molecular research : GMR 2015 14 (4): 18218-28. Sun Y, Zhou R B, Chen D |
| Common APOC3 variants are associated with circulating ApoC-III and VLDL cholesterol but not with total apolipoprotein B and coronary artery disease. Atherosclerosis 2020 Sep 311 84-90. Silbernagel Günther, Scharnagl Hubert, Kleber Marcus E, Hoffmann Michael M, Delgado Graciela, Stojakovic Tatjana, Gary Thomas, Zeng Lingyao, Ritsch Andreas, Zewinger Stephen, Speer Thimoteus, Schunkert Heribert, Landmesser Ulf, März Winfried, Grammer Tanja |
| APOC3rs2854116, PNPLA3rs738409, and TM6SF2rs58542926 polymorphisms might influence predisposition of NAFLD: A meta-analysis. IUBMB life 2020 Jun . Tong Mingjiong, Wang Fengyo |
| Association between APOC3 polymorphisms and non-alcoholic fatty liver disease risk: a meta-analysis. African health sciences 2020 Dec 20 (4): 1800-1808. Wang Jun, Ye Chuncui, Fei Suju |
| A PRISMA-compliant meta-analysis of apolipoprotein C3 polymorphisms and nonalcoholic fatty liver disease. Journal of the Chinese Medical Association : JCMA 2021 Jun . Chen Bing-Feng, Chien Yeuh, Tsai Pin-Hsing, Perng Pang-Chung, Yang Yi-Ping, Hsueh Kuan-Chun, Liu Chia-Hung, Wang Yuan-Hu |
| Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk. European heart journal open 2024 6 4 (3): oeae035. Fredrik Landfors, Peter Henneman, Elin Chorell, Stefan K Nilsson, Sander Kerst |
- Page last reviewed:Feb 1, 2024
- Content source: